VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593

**Semantic type:** Pharmacologic Substance

**Definition:** An oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity. TAK-593 selectively binds to and inhibits VEGFR and PDGFR, which may result in the inhibition of angiogenesis and tumor cell proliferation.

**Synonyms:** - TAK-593 - TAK-593